Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Re: Cautious:When will institutions buy 50% to 70% of PTSC stock / oscar
1
Dec 06, 2007 04:57AM
2
Dec 06, 2007 05:00AM
7
Dec 06, 2007 05:44AM

Dec 06, 2007 06:35AM
1
Dec 06, 2007 07:12AM

Your list makes sense. I would add to it a resonable biz plan would need to have been publicly discussed by JT.

IMO, institutional investors look for forward growth and vision. JT and gang have stated they are doing exactly that -- looking for M & A candidates. Once their plan(s) are know and after the current legal issues are cleared, PTSC could very well be on some of the short lists for institutional ownership, IMO.

John

2
Dec 06, 2007 07:37AM

Dec 06, 2007 01:44PM
Share
New Message
Please login to post a reply